MAULDIN JOHN F

Average Profitability
77.12%
Insider Buys Quantity
12
Insider Buys Sum
$109,058.54
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of MAULDIN JOHN F

The largest purchase of all time was on 2012-04-24 and amounted to 7694 shares of Galectin Therapeutics Inc. for $22,620.

Biography of MAULDIN JOHN F

No biography is available at this moment.

2014-01-02PurchaseGalectin Therapeutics Inc.
GALT
director
1,236
0.0061%
$8.01$9,900+38.76%
2013-12-02PurchaseGalectin Therapeutics Inc.
GALT
director
1,218
0.0074%
$8.20$9,984+40.68%
2013-11-01PurchaseGalectin Therapeutics Inc.
GALT
director
956
0.0064%
$10.43$9,970+22.21%
2013-10-02PurchaseGalectin Therapeutics Inc.
GALT
director
250
0.0015%
$9.97$2,493+12.04%
2013-10-01PurchaseGalectin Therapeutics Inc.
GALT
director
752
0.0044%
$9.96$7,492+12.38%
2013-09-04PurchaseGalectin Therapeutics Inc.
GALT
director
1,352
0.0081%
$7.38$9,976+54.67%
2013-08-05PurchaseGalectin Therapeutics Inc.
GALT
director
1,680
0.0101%
$5.94$9,976+93.8%
2013-07-03PurchaseGalectin Therapeutics Inc.
GALT
director
1,752
0.0104%
$4.23$7,417+160.83%
2013-07-01PurchaseGalectin Therapeutics Inc.
GALT
director
600
0.0034%
$4.24$2,546+147.96%
2013-06-03PurchaseGalectin Therapeutics Inc.
GALT
director
2,352
0.0142%
$4.21$9,909+134.38%
2012-04-25PurchaseGalectin Therapeutics Inc.
GALT
director
2,200
0.0137%
$3.08$6,776-29.94%
2012-04-24PurchaseGalectin Therapeutics Inc.
GALT
director
7,694
0.0474%
$2.94$22,620-27.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.